Species differences in the pharmacokinetics of KW-7158 [(2S)-(+)-3,3,3-Trifluoro-2-hydroxy-2-methyl-N-(5,5,10-trioxo-4,10-dihydrothieno[3,2-c][1]benzothiepin-9-yl)propanamide]: formation of hydrolyzed metabolite in human and animals

Author: Maeda Hiroshi   Kodaira Hiroshi   Fujita Kazuhiro   Kobayashi Hiroyuki   Ushiki Junko   Nakanishi Takeo   Tamai Ikumi  

Publisher: Informa Healthcare

ISSN: 1366-5928

Source: Xenobiotica, Vol.42, Iss.7, 2012-07, pp. : 649-659

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content